News
CTI raises $100-million to invest in early-stage Canadian life sciences
Recent news coverage relating to the close of our third fund
CTI LIFE SCIENCES FUND HOLDS $100M INITIAL CLOSE FOR 3RD FUND
Recent news coverage relating to the close of our third fund
CTI Life Sciences unveils new fund
Recent news coverage relating to the close of our third fund
Luca Santarelli's VectivBio
Luca Santarelli's VectivBio buys out small Massachusetts biotech, redoubling focus on metabolic disease
CTI Life Sciences Fund
CTI Life Sciences Fund Successfully Raises $100 Million As A First Tranche of its Third Venture Capital Fund
Bristol Myers Squib
Bristol Myers Squibb Receives European Commission Approval for Inrebic® (fedratinib) for Adult Patients with Newly Diagnosed and Previously Treated Myelofibrosis
VectivBio Announces
VectivBio Announces First Patient Dosed in Pivotal Phase 3 Trial of Apraglutide for the Treatment of Short Bowel Syndrome